SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRASG12D inhibitor in KRAS LUAD

AdminUncategorized2 months ago29 Views

Proceedings of the National Academy of Sciences, Volume 122, Issue 11, March 2025.
SignificanceOur data demonstrate the absence of overt toxicity and the therapeutic efficacy of the specific SOS1 inhibitor BI-3406 when used as a single therapy agent or in combination with the specific KRASG12Dinhibitor MRTX1133…
Read More

0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Leave a reply

Recent Comments

No comments to show.

Stay Informed With the Latest & Most Important News

I consent to receive newsletter via email. For further information, please review our Privacy Policy

Advertisement

Loading Next Post...
Follow
Sign In/Sign Up Sidebar Search Trending 0 Cart
Popular Now
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...

Cart
Cart updating

ShopYour cart is currently is empty. You could visit our shop and start shopping.